Patents matching “LTD.”

US 8455564

Dental composition and composite resin

JGC Catalysts and Chemicals Ltd. · Granted Jun 4, 2013 · Expires May 30, 2033

US 8449876

Human lysosomal proteins from plant cell culture

Protalix Ltd. · Granted May 28, 2013 · Expires May 23, 2033

US 8440739

Dental composition and composite resin

JGC Catalysts and Chemicals Ltd. · Granted May 14, 2013 · Expires May 9, 2033

US 8436154

Crystallizing method of erythromycin

SUNSHINE LAKE PHARMA CO., LTD. · Granted May 7, 2013 · Expires May 2, 2033

US 8436078

Dental composition and composite resin

JGC Catalysts and Chemicals Ltd. · Granted May 7, 2013 · Expires May 2, 2033

US 8426585

Compounds comprising a spiro-ring

SUNSHINE LAKE PHARMA CO., LTD. · Granted Apr 23, 2013 · Expires Apr 18, 2033

US 8426385

Pharmaceutical composition comprising cyclodextrin paclitaxel inclusion and preparation method thereof

Hainan Hdeton Science and Technology Co., Ltd. · Granted Apr 23, 2013 · Expires Apr 18, 2033

US 8414918

Stable imatinib compositions

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 9, 2013 · Expires Apr 4, 2033

US 8415314

Methods for treating multiple sclerosis using antisense oligonucleotides

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 9, 2013 · Expires Apr 4, 2033

US 8414920

Pharmaceutical composition containing irbesartan

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 9, 2013 · Expires Apr 4, 2033

US 8410288

Polymorphs of Saxagliptin hydrochloride and processes for preparing them

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 2, 2013 · Expires Mar 28, 2033

US 8391959

Composition for improving efficiency of drug delivery

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Mar 5, 2013 · Expires Feb 28, 2033

US 8389228

Process for the measurement of the potency of glatiramer acetate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 5, 2013 · Expires Feb 28, 2033

US 8383645

Stable laquinimod preparations

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 26, 2013 · Expires Feb 21, 2033

US 8367105

Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 5, 2013 · Expires Jan 31, 2033

US 8367052

Methods for promoting protection and regeneration of bone marrow using CXCL9 and anti-CXCL9 antibodies

GENERAL REGENERATIVES, LTD. · Granted Feb 5, 2013 · Expires Jan 31, 2033

US 8367106

Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 5, 2013 · Expires Jan 31, 2033

US 8361743

Biological production of zeaxanthin and carotenoid biosynthesis control

Aquapharm Bio-Discovery Ltd. · Granted Jan 29, 2013 · Expires Jan 24, 2033

US 8350065

5,6-dimethyl xanthone-4-acetic acid derivatives and method of preparing the same

GRANDPHARMA (CHINA) CO., LTD. · Granted Jan 8, 2013 · Expires Jan 3, 2033

US 8343969

Bromo-phenyl substituted thiazolyl dihydropyrimidines

SUNSHINE LAKE PHARMA CO., LTD. · Granted Jan 1, 2013 · Expires Dec 27, 2032

US 8343549

Therapeutic uses of Dunaliella powder

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jan 1, 2013 · Expires Dec 27, 2032

US 8343511

Methods and compositions for treating inflammatory bowel disease

RedHill Biopharma Ltd. · Granted Jan 1, 2013 · Expires Dec 27, 2032

US 8334409

Process for purifying rasagiline base

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 18, 2012 · Expires Dec 13, 2032

US 8329696

Solid state forms of sitagliptin salts

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 11, 2012 · Expires Dec 6, 2032